Css LLC Editas Medicine, Inc. Put Options Transaction History

Css LLC

  • $999 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$26.55 - $40.57 $1.56 Million - $2.39 Million
-58,900 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$39.27 - $72.94 $2.31 Million - $4.3 Million
58,900 New
58,900 $2.42 Million
Q1 2021

May 17, 2021
SELL
$39.71 - $90.58 $520,201 - $1.19 Million
-13,100 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$27.07 - $84.35 $354,617 - $1.1 Million
13,100 New
13,100 $919,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
56.9M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $92.1M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email